Back to List
February 01, 2017

ZO SKIN HEALTH, INC ANNOUNCES ACQUISITION OF REFISSA® FROM SUNEVA MEDICAL

February 1, 2017 - ZO Skin Health, Inc announced today that it has acquired the worldwide rights to ReFissa®, as well as its generic equivalent tretinoin, from Suneva Medical. Refissa® is the only FDA-approved prescription cream with a .05% strength emollient base designed to reduce fine facial wrinkles, correct irregular pigmentation, and smooth substantial skin roughness.

“This is a strategic acquisition for us,” says Mark Williams, President, CEO and General Counsel for ZO Skin Health, Inc. “It allows the company to complete founder Dr. Zein Obagi’s protocols, specifically those for hyperpigmentation. ReFissa® is a best-in-class product that will deliver superior results and complement our existing portfolio of products.”

A derivative of vitamin A, ReFissa’s® new formulation of tretinoin has been proven in a clinical trial to be effective in the reduction of fine lines and tactile roughness of the skin, as well as in the treatment of irregular pigmentation from the sun. “Vitamin A has always been a critical component of my treatment protocol for my patients,” says Zein Obagi, MD, Founder and Medical Director of ZO Skin Health, Inc. “It works in tandem with the ZO® Melamix® skin lightener to help blend the skin to create a more even skin tone. By acquiring ReFissa®, we are able to offer to all of our physician partners a product with superior anti-aging and skin tone benefits so they can continue to prescribe in accordance with my protocols.”

Financial terms for the acquisition were not disclosed.

ABOUT ZO® Skin Health: Combining the latest cutting-edge science with Dr. Zein Obagi’s extensive clinical experience, ZO® Skin Health offers comprehensive skincare products and programs for both physicians and their patients. Designed in accordance with Dr. Obagi’s GSRTM - Getting Skin Ready program, each product was specifically formulated to treat skin conditions on its own or in part of a step-by-step regimen. In addition to its product line, ZO® Skin Health also offers a series of skin health seminars and clinical training programs to physicians through a variety of educational programs. Committed to bridging the gap between therapeutic treatments and daily care, ZO® Skin Health continues to innovate the most effective skincare products for all skin types.

ABOUT Suneva Medical Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. Suneva currently markets Bellafill ® and ReGenica® Skincare in the U.S, Canada. and Hong Kong. For more information visit www.sunevamedical.com.


About ZO Skin Health, Inc.
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health around the globe. Utilizing cutting-edge science and Dr. Zein Obagi's extensive clinical experience creating treatments and regimens for healthy skin, ZO Skin Health, Inc. provides comprehensive skincare programs for physicians and their patients. Committed to advancing effective treatments for healthy skin, ZO Skin Health, Inc. supports physicians' practices through skin health seminars and clinical training, and patients through a variety of educational programs. As a result, ZO Skin Health, Inc. is focused on providing products and protocols that bridge the gap between therapeutic treatments and daily care that allow patients to experience continuously healthy skin regardless of their age or unique skin condition. For more information, visit www.zoskinhealth.com.

About Zein Obagi, MD
Researcher, innovator, scientist, published author, lecturer and board-certified dermatologist, Dr. Zein Obagi has achieved international renown as a leading authority on skin rejuvenation. He is the ZO Skin Health, Inc. founder and medical director and is responsible for the development of new skincare treatments, protocols and products to achieve healthy skin.

Over twenty years ago, Dr. Zein Obagi pioneered the concept of skin health and conceived of, and brought to market, a line of medical skincare products – the original Obagi Nu-Derm® System – that transformed aging skin. Dr. Obagi founded WorldWide Products, which produced and marketed the original Obagi Nu-Derm® System. At that time, Dr. Obagi merely intended to challenge the norms of traditional skin care. Instead he shattered the status quo. Today his ideas about skin health are no longer surprising; they have become mainstream. Subsequently, WorldWide was purchased by Obagi Medical Products, Inc., a company with which Dr. Obagi no longer has any affiliation, but which retained his family name (Obagi®) as their trademark.

ZO Skin Health, Inc. and Dr. Obagi have no business relationship with Obagi Medical Products, and Obagi Medical Products does not sell or endorse using any ZO® product. "ZO" is a registered trademark of ZO Skin Health, Inc. "Obagi" and “Obagi Nu-Derm” are registered trademarks of Obagi Medical Products, Inc.

Find us on Facebook at ZO Skin Health by Zein Obagi, MD.
Follow us on Twitter @ZO Skin Health.
Engage with us on Instagram ZO Skin Health.